“…In in vitro tests most isolates of C. albicans are susceptible to X1.0 mg/ml of FCZ, an achievable blood level, but blood levels may not correlate with clinical outcome because of the grave condition of the patient [10]. FCZ resistance may develop in most clinically important Candida spp.…”